PUBLISHER: The Business Research Company | PRODUCT CODE: 1957630
PUBLISHER: The Business Research Company | PRODUCT CODE: 1957630
Pharmaceutical pellets are a type of multi-particulate dosage form produced by combining active drugs with finely milled excipients to form small, free-flowing spherical or semi-spherical particles. They are commonly used to develop dosage forms that provide prolonged or controlled drug release.
The main technologies used in the production of pharmaceutical pellets include extrusion, fluid bed granulation, dry powder layering, solution and suspension layering, spray congealing, and spray drying. Extrusion is a manufacturing process in which material is forced through a die of a specific cross-section to produce particles with a uniform shape and size. The drug release mechanisms involved include diffusion, erosion, and osmosis, and pellets can be prepared using direct, melt, wet, and dry techniques. These pellets are utilized by various end users, including pharmaceutical and nutraceutical industries.
Tariffs have influenced the pharmaceutical pellets market by increasing the cost of imported processing equipment, coating materials, and specialty excipients used in pelletization. These impacts are most pronounced across advanced manufacturing technologies such as fluid bed granulation, spray drying, and solution layering, with Asia-Pacific and Europe being the most affected due to their dependence on cross-border raw material and machinery trade. Pharmaceutical manufacturers have experienced margin pressure and longer lead times, particularly in high-volume sustained-release formulations. However, tariffs have also encouraged localization of pellet manufacturing, investments in domestic production capabilities, and greater adoption of cost-efficient processing techniques, supporting long-term supply chain resilience.
The pharmaceutical pellets market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical pellets market statistics, including pharmaceutical pellets industry global market size, regional shares, competitors with a pharmaceutical pellets market share, detailed pharmaceutical pellets market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical pellets industry. This pharmaceutical pellets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pharmaceutical pellets market size has grown rapidly in recent years. It will grow from $2.01 billion in 2025 to $2.24 billion in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to growing prevalence of chronic diseases, increasing demand for modified release dosage forms, advancements in extrusion and fluid bed technologies, expansion of pharmaceutical manufacturing capacities, rising focus on patient compliance.
The pharmaceutical pellets market size is expected to see rapid growth in the next few years. It will grow to $3.48 billion in 2030 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to growth in precision drug delivery solutions, increasing adoption of pellets in combination therapies, rising nutraceutical and functional ingredient demand, innovation in solvent-free and melt-based techniques, expansion of contract manufacturing organizations. Major trends in the forecast period include rising adoption of multi-particulate drug delivery systems, growing demand for controlled and sustained release formulations, increasing use of pellets in capsule and sachet dosage forms, expansion of pelletization in nutraceutical applications, technological advancements in coating and layering techniques.
The growing adoption of personalized medicine is expected to drive the expansion of the pharmaceutical pellets market in the coming years. Personalized medicine involves customizing medical treatment based on the unique characteristics of individual patients, often supported by molecular diagnostics and biomarker analysis. The increasing adoption of personalized medicine is largely fueled by advancements in genomics and diagnostic technologies that allow therapies to be precisely aligned with a patient's genetic makeup. Pharmaceutical pellets are well suited to this approach, as they enable flexible manufacturing, small-batch production, and accurately controlled drug delivery, making them ideal for personalized dosing regimens and combination therapies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit advocacy organization, 26 new personalized treatments were approved by the U.S. Food and Drug Administration in 2023, including 20 new molecular entities and six gene- or cell-based therapies, compared with six rare disease therapies approved in 2022. Therefore, the increasing adoption of personalized medicine is contributing to the growth of the pharmaceutical pellets market.
Major companies operating in the pharmaceutical pellets market are concentrating on the development of advanced solutions to enhance particle engineering, ensure high containment, and maintain precision in drug formulation processes. Particle engineering platforms are technological systems that allow controlled production of pharmaceutical pellets with specific size, shape, and potency, while ensuring safety, effectiveness, and compliance with regulatory standards. For example, in May 2024, Schedio SA, a US-based engineering company, introduced the High Potent Pilot Particle Engineering Platform. This advanced system supports up to 465 configurations and integrates with spray dryers and jet mills, with the goal of improving particle engineering for high-potency pharmaceutical compounds. The platform incorporates high-containment features and user-friendly controls to ensure safety, precision, and regulatory compliance during pharmaceutical manufacturing.
In March 2023, Colorcon Inc., a US-based pharmaceutical film coating company, acquired Airnov Healthcare Packaging for an undisclosed amount. This acquisition strengthened Colorcon's portfolio by adding specialized capabilities in controlled-atmosphere packaging, including solutions for moisture and oxygen protection. As a result, Colorcon expanded its stability and moisture management offerings for the pharmaceutical industry. Airnov Healthcare Packaging is a France-based company specializing in controlled-atmosphere packaging that uses active materials, advanced plastic processing, and functional design to protect pharmaceutical products from the harmful effects of moisture and oxygen.
Major companies operating in the pharmaceutical pellets market are Abbott Laboratories, Takeda, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Eisai Co. Ltd., Colorcon Inc., Nordic Sugar AB, Pfizer, Merck & Co., Manus Aktteva Biopharma LLP, Thexa Pharma (P) Limited, Avanscure Lifesciences Private Limited, MB Sugars & Pharmaceuticals Limited, CIL Laboratories Pvt Ltd, Sainor Pharma Pvt Ltd, Umang Pharmatech Pvt Ltd, Nami Lifesciences Pvt Ltd, Lograns Pharma Private Limited, Rainbow Health Care Products, Chemit Laboratories, Concord Drugs Limited, Nanjing Joyfulchem Co. Ltd., Praful International Corporation, Pellets Pharma Limited, Vision Pharmacoat Pvt Ltd, Spansules Pharma, Ravoos Laboratories Ltd
North America was the largest region in the pharmaceutical pellets market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical pellets market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pharmaceutical pellets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pharmaceutical pellets market consists of revenues earned by entities by providing services such as formulation development, manufacturing and production, customization, and tailoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical pellets market also includes sales of granulated itraconazole pellets and Rabeprazole pellets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pharmaceutical Pellets Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pharmaceutical pellets market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pharmaceutical pellets ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical pellets market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.